Pediatrix Medical Group, Inc.
For the period ended Mar 31, 2026. Filed May 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Rule 10b5-1 Trading Plans
During the three months ended March 31, 2026, none of the Company’s directors or officers adopted orterminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K).
Executive Transition
On May 1, 2026, the Company and Ms. Mary Ann E. Moore, the Executive Vice President, General Counsel, Chief Administrative Officer and Secretary of the Company, determined that Ms. Moore would transition from her role at the Company, after 20 years as a leader of our organization. The transition is expected to occur prior to the end of the calendar year.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.